1-4 of 4
Maja Milanovic, PhD
Close
Sort by
Journal Articles

Chemotherapy-Induced Senescence Reprograms Lymphoma and Leukemia Cells into Latent Cancer Stem Cells That Are Susceptible to Conceptually Novel Treatments

Clemens A. Schmitt, MD, Maja Milanovic, PhD, Henry Daebritz, Zhen Zhao, MD PhD, Andreas Trumpp, PhD
Journal: Blood
Blood (2014) 124 (21): 4788.
https://doi.org/10.1182/blood.V124.21.4788.4788
Published: 2014
Journal Articles

Elevated ROS Levels in Response to CD20-Targeting Enhance Senescence Entry after Immunochemotherapy in Human B-Cell Lymphoma

J. Henry M. Däbritz, MD, Yong Yu, Maja Milanovic, PhD, Jan R. Dörr, Andreas M. Kaufmann, MD, Mathias T. Rosenfeldt, MD, Bernd Dörken, MD PhD, Clemens A. Schmitt, MD
Journal: Blood
Blood (2014) 124 (21): 2240.
https://doi.org/10.1182/blood.V124.21.2240.2240
Published: 2014
Journal Articles

Acquired Stem Cell Properties In Therapy-Induced Senescence Of Lymphomas and Acute Leukemias In Vitro and In Vivo

J. Henry M. Däbritz, Maja Milanovic, PhD, Zhen Zhao, MD, PhD, Jan R. Dörr, Yong Yu, Dido Lenze, PhD, Bernd Dörken, Michael Hummel, PhD, Christoph Dieterich, PhD, Scott W. Lowe, PhD, Clemens A. Schmitt, MD
Journal: Blood
Blood (2013) 122 (21): 4193.
https://doi.org/10.1182/blood.V122.21.4193.4193
Published: 2013
Journal Articles

H3K9me3-Governed Senescence In Tumor Development and Lymphoma Treatment

Julia Kase, MD, Jan Dörr, Yong Yu, Maja Milanovic, PhD, Sujuan Ji, PhD, Sandra Spiesicke-Wegener, Philipp Lohneis, MD, Bernd Dörken, Soyoung Lee, PhD, Clemens A. Schmitt, MD
Journal: Blood
Blood (2013) 122 (21): 345.
https://doi.org/10.1182/blood.V122.21.345.345
Published: 2013